Angela Eubanks
Psychiatry · Macon, GANPI 1205468840
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $22,950 of the $29,525 with a category attached, or 77.7%. Neurocrine Biosciences, Inc. accounts for 70.5% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2021 at $21,783 and has fallen 97.8% since, to $473 in 2025. Among psychiatry clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 226 payments — averaging $130.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$21K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$6K
- Johnson & Johnson$519
- Teva Pharmaceuticals USA, Inc.$516
- Alkermes, Inc.$469
- AbbVie$351
- plus $1K from 7 others
What the payments were for
- Consulting fees$1,3134%
- Speaking & faculty fees$22,95078%
- Travel & lodging$7262%
- Food & beverage$4,48215%
- Education$550%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 28 | $20,811 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 38 | $5,566 |
| Johnson & Johnson | 26 | $519 |
| Teva Pharmaceuticals USA, Inc. | 25 | $516 |
| Alkermes, Inc. | 21 | $469 |
| AbbVie | 23 | $351 |
| Indivior Inc. | 14 | $321 |
| Otsuka America Pharmaceutical, Inc. | 14 | $286 |
| Braeburn Inc. | 9 | $219 |
| E.r. Squibb & Sons, L.L.C. | 10 | $186 |
| Lundbeck LLC | 8 | $131 |
| Sunovion Pharmaceuticals Inc. | 8 | $125 |
| Noven Therapeutics, LLC | 2 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INGREZZA$20,592
- CAPLYTA$5,006
- AUSTEDO$124
- INVEGA SUSTENNA$123
- INVEGA TRINZA$123
- VIVITROL$116
How this compares
$29,525 in reported general payments places this provider in the 95th percentile of 900 psychiatry providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 12 | $13,110 |
| Olanzapine | 12 | $363 |
| Divalproex Sodium | 12 | $263 |
| Haloperidol | 13 | $162 |
| Buspirone Hcl | 12 | $144 |
| Benztropine Mesylate | 16 | $117 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Macon
- Richard PettyLoganville$2.9M
- Ann GrooverCalhoun$1.4M
- Todd AntinDecatur$1M
- Michael BanovMarietta$733K
- Ben HunterBrookhaven$499K
- Joel MorganValdosta$337K
- Munjal ShroffSmyrna$316K
- David PurselleAtlanta$307K
- Jose CangianoAthens$244K
- Michael BurkeAtlanta$217K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.